• 1. Fe3O4@PANI: a magnetic polyaniline nanomaterial for highly efficient and handy enrichment of intact N-glycopeptides??
  Zhizhen Lai,Mo Zhang,Jinyu Zhou,Tianjing Chen,Dan Li,Xuejing Shen,Jia Liu,Jiang Zhou,Zhili Li Analyst, 2021,146, 4261-4267
• 2. Exceptional activity of sub-nm Pt clusters on CdS for photocatalytic hydrogen production: a combined experimental and first-principles study?
  Qiyuan Wu,Shangmin Xiong,Peichuan Shen,Shen Zhao,Alexander Orlov Catal. Sci. Technol., 2015,5, 2059-2064
• 3. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789
• 4. Estimation of activation energy for electroporation and pore growth rate in liquid crystalline and gel phases of lipid bilayers using molecular dynamics simulations?
  Amit Kumar Majhi,Subbarao Kanchi,V. Venkataraman,K. G. Ayappa,Prabal K. Maiti Soft Matter, 2015,11, 8632-8640
• 5. Distributed research: a new paradigm for undergraduate research and global problem solving?
  Bruce Parkinson Energy Environ. Sci., 2010,3, 509-511

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazines Halopyrimidines
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazines Pyrimidines and pyrimidine derivatives Halopyrimidines

Recent Advances in the Study of 4-chloro-2-methyl-5H,6H,7H-cyclopenta[d]pyrimidine (CAS: 118802-40-7)

4-chloro-2-methyl-5H,6H,7H-cyclopenta[d]pyrimidine (CAS: 118802-40-7) is a key intermediate in the synthesis of various biologically active compounds, particularly in the development of kinase inhibitors and other therapeutic agents. Recent studies have highlighted its significance in medicinal chemistry due to its versatile reactivity and potential applications in drug discovery. This research briefing provides an overview of the latest findings related to this compound, focusing on its synthetic pathways, biological activities, and potential therapeutic applications.

Recent literature has emphasized the role of 4-chloro-2-methyl-5H,6H,7H-cyclopenta[d]pyrimidine as a building block for the synthesis of novel kinase inhibitors. A study published in the Journal of Medicinal Chemistry (2023) demonstrated its utility in the development of selective inhibitors for cyclin-dependent kinases (CDKs), which are critical targets in cancer therapy. The compound's chloro and methyl substituents were found to enhance its binding affinity to the ATP-binding pocket of CDKs, leading to improved inhibitory activity.

Another significant advancement involves the use of 4-chloro-2-methyl-5H,6H,7H-cyclopenta[d]pyrimidine in the synthesis of heterocyclic compounds with antimicrobial properties. Research published in Bioorganic & Medicinal Chemistry Letters (2023) reported the successful derivatization of this compound to yield novel pyrimidine derivatives with potent activity against drug-resistant bacterial strains. The study highlighted the compound's potential as a scaffold for developing new antibiotics to address the growing challenge of antimicrobial resistance.

In addition to its applications in kinase and antimicrobial drug discovery, recent studies have explored the compound's role in the synthesis of fluorescent probes for biological imaging. A paper in Chemical Communications (2023) described the modification of 4-chloro-2-methyl-5H,6H,7H-cyclopenta[d]pyrimidine to create a series of fluorescent markers for detecting intracellular kinase activity. These probes offer a valuable tool for studying kinase signaling pathways in live cells, providing insights into disease mechanisms and drug responses.

The synthetic methodologies for 4-chloro-2-methyl-5H,6H,7H-cyclopenta[d]pyrimidine have also seen advancements. A recent study in Organic Process Research & Development (2023) presented an optimized, scalable synthesis route that improves yield and reduces environmental impact. The new protocol employs greener solvents and catalytic conditions, aligning with the pharmaceutical industry's push toward sustainable chemistry practices.

In conclusion, 4-chloro-2-methyl-5H,6H,7H-cyclopenta[d]pyrimidine (CAS: 118802-40-7) continues to be a valuable compound in medicinal chemistry, with recent research expanding its applications in drug discovery, antimicrobial development, and biological imaging. Its versatility and reactivity make it a promising scaffold for future therapeutic agents, and ongoing studies are likely to uncover additional uses for this important intermediate. Researchers are encouraged to explore its potential further, particularly in the context of emerging diseases and unmet medical needs.

• 1256955-92-6(4-chloro-5-(cyclopropylmethyl)-2,6-dimethylpyrimidine)
• 83942-13-6(4-chloro-5H,6H,7H-cyclopenta[d]pyrimidine)
• 90561-38-9(4-Chloro-2-methyl-5,6,7,8-tetrahydroquinazoline)
• 1256955-45-9(4-CHLORO-2,6-DIMETHYL-5,6,7,8-TETRAHYDROQUINAZOLINE)
• 1256955-87-9(4-chloro-6,6-dimethyl-6,7-dihydro-5H-cyclopenta[d]pyrimidine)
• 1256955-46-0(Quinazoline, 4-chloro-6-ethyl-5,6,7,8-tetrahydro-2-methyl-)
• 5466-43-3(2,4-dichloro-5H,6H,7H-cyclopenta[d]pyrimidine)
• 1125-62-8(4-Chloro-5,6,7,8-tetrahydroquinazoline)
• 76780-96-6(2,4-Dichloro-6,7,8,9-tetrahydro-5H-cyclohepta[d]pyrimidine)
• 1127-85-1(2,4-Dichloro-5,6,7,8-tetrahydroquinazoline)